BIRC3 and leukemia: For the triterpenoid CDDO-Me it was demonstrated that it is able to suppress NF-κB and NF-κB-dependent gene products that mediate cell survival, including survivin, Bcl-2 and cIAP2 in human leukaemia and ovarian cancer cells [73, 74].